Search research articles
Contact Us
Filters
Showing results (191-200 of 208) with videos related to
Page
of 21
Sort By:
Journal of Translational Medicine
|
October 29, 2014
Future perspectives in melanoma research: meeting report from the "Melanoma Bridge", Napoli, December 5th-8th 2013
Paolo A Ascierto, Antonio M Grimaldi, Ana Carrizosa Anderson, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
June 13, 2018
Merkel Cell Carcinoma, Version 1.2018, NCCN Clinical Practice Guidelines in Oncology
Christopher K Bichakjian, Thomas Olencki, Sumaira Z Aasi, et al.
JCO Precision Oncology
|
March 21, 2024
Plasma Proteome-Based Test for First-Line Treatment Selection in Metastatic Non-Small Cell Lung Cancer
Petros Christopoulos, Michal Harel, Kimberly McGregor, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
November 7, 2023
Basal Cell Skin Cancer, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology
Chrysalyne D Schmults, Rachel Blitzblau, Sumaira Z Aasi, et al.
Journal of Translational Medicine
|
November 17, 2016
Future perspectives in melanoma research : Meeting report from the "Melanoma Bridge". Napoli, December 1st-4th 2015
Paolo A Ascierto, Sanjiv Agarwala, Gerardo Botti, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
December 13, 2021
NCCN Guidelines® Insights: Squamous Cell Skin Cancer, Version 1.2022
Chrysalyne D Schmults, Rachel Blitzblau, Sumaira Z Aasi, et al.
Journal for Immunotherapy of Cancer
|
May 11, 2018
Predicting response to checkpoint inhibitors in melanoma beyond PD-L1 and mutational burden
Carl Morrison, Sarabjot Pabla, Jeffrey M Conroy, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
January 20, 2024
NCCN Guidelines® Insights: Merkel Cell Carcinoma, Version 1.2024
Chrysalyne D Schmults, Rachel Blitzblau, Sumaira Z Aasi, et al.
The Lancet. Oncology
|
June 28, 2015
Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial
Antoni Ribas, Igor Puzanov, Reinhard Dummer, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
June 15, 2026
Melanoma: Cutaneous, Version 2.2026, NCCN Clinical Practice Guidelines In Oncology
Susan M Swetter, Douglas Johnson, Mark R Albertini, et al.
Page
of 21
Search research articles
Search
Showing results (191-200 of 208) with videos related to
Sort By:
Page
of 21
Journal of Translational Medicine
|
October 29, 2014
Future perspectives in melanoma research: meeting report from the "Melanoma Bridge", Napoli, December 5th-8th 2013
Paolo A Ascierto, Antonio M Grimaldi, Ana Carrizosa Anderson, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
June 13, 2018
Merkel Cell Carcinoma, Version 1.2018, NCCN Clinical Practice Guidelines in Oncology
Christopher K Bichakjian, Thomas Olencki, Sumaira Z Aasi, et al.
JCO Precision Oncology
|
March 21, 2024
Plasma Proteome-Based Test for First-Line Treatment Selection in Metastatic Non-Small Cell Lung Cancer
Petros Christopoulos, Michal Harel, Kimberly McGregor, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
November 7, 2023
Basal Cell Skin Cancer, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology
Chrysalyne D Schmults, Rachel Blitzblau, Sumaira Z Aasi, et al.
Journal of Translational Medicine
|
November 17, 2016
Future perspectives in melanoma research : Meeting report from the "Melanoma Bridge". Napoli, December 1st-4th 2015
Paolo A Ascierto, Sanjiv Agarwala, Gerardo Botti, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
December 13, 2021
NCCN Guidelines® Insights: Squamous Cell Skin Cancer, Version 1.2022
Chrysalyne D Schmults, Rachel Blitzblau, Sumaira Z Aasi, et al.
Journal for Immunotherapy of Cancer
|
May 11, 2018
Predicting response to checkpoint inhibitors in melanoma beyond PD-L1 and mutational burden
Carl Morrison, Sarabjot Pabla, Jeffrey M Conroy, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
January 20, 2024
NCCN Guidelines® Insights: Merkel Cell Carcinoma, Version 1.2024
Chrysalyne D Schmults, Rachel Blitzblau, Sumaira Z Aasi, et al.
The Lancet. Oncology
|
June 28, 2015
Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial
Antoni Ribas, Igor Puzanov, Reinhard Dummer, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
June 15, 2026
Melanoma: Cutaneous, Version 2.2026, NCCN Clinical Practice Guidelines In Oncology
Susan M Swetter, Douglas Johnson, Mark R Albertini, et al.
Page
of 21